TRANSET FRACTURE FIXATION SYSTEM

K033717 · Bonutti Research, Inc. · HTY · Feb 25, 2004 · Orthopedic

Device Facts

Record IDK033717
Device NameTRANSET FRACTURE FIXATION SYSTEM
ApplicantBonutti Research, Inc.
Product CodeHTY · Orthopedic
Decision DateFeb 25, 2004
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3040
Device ClassClass 2
AttributesTherapeutic

Intended Use

The TranSet™ Fracture Fixation System is indicated as an adjunct in fracture repair involving metaphyseal and periarticular small bone fragments where screws are not indicated. It may also be used as an adjunct to external and intramedullary fixation systems involving fixation plates and rods, with fracture braces and casting, and with bone graft substitutes. The system is also indicated in ligament and tendon repair and reconstruction associated with fractures and soft tissue reattachment including ligament/tendon avulsions and meniscal repairs. The system consists of both absorbable and titanium fixation buttons used with up to USP Size No. 5-braided suture and are not intended for reuse. The system may also be used with the Unity Ultrasonic Fixation seat for tissue approximation and ligation when using USP Size No. 2-0 through 2-braided suture. Custom manual surgical instrumentation for button insertion and a sterilization tray complete the TranSet™ Fracture Fixation System. The TranSet™ Fracture Fixation System is not indicated for use in intra-articular sites.

Device Story

TranSet™ Fracture Fixation System consists of cylindrical buttons (poly-L-lactic acid or titanium alloy) and manual surgical instrumentation. Buttons are applied to outer bone cortex or soft tissue repair sites; suture runs across fracture site to provide stabilization, linear fixation, and compression to promote healing. Buttons act as fixation posts, distributing suture tension to prevent tearing. Absorbable buttons degrade over time; titanium buttons may be removed per surgeon preference. Used in orthopedic procedures by surgeons. System includes sterilization tray for autoclaving. Benefits include stabilization of bone/tissue fragments and elimination of suture tearing.

Clinical Evidence

Bench testing only. Performance testing compared mechanical strengths and failure modes of absorbable and titanium buttons against stainless steel Steinmann Pins, demonstrating statistical equivalence.

Technological Characteristics

Materials: Poly-L-lactic acid (absorbable) and titanium alloy. Form factor: Cylindrical buttons. Energy source: None (manual instrumentation). Connectivity: None. Sterilization: Provided sterile (buttons); manual instrumentation requires autoclaving.

Indications for Use

Indicated for fracture repair of metaphyseal and periarticular small bone fragments where screws are not indicated; adjunct to external/intramedullary fixation, fracture braces, casting, and bone graft substitutes; ligament/tendon repair and reconstruction associated with fractures; soft tissue reattachment including ligament/tendon avulsions and meniscal repairs. Contraindicated for intra-articular sites.

Regulatory Classification

Identification

A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo for "Multitak SS" in a bold, black font. Underneath the logo, in a smaller font, it says "FROM BONUTTI RESEARCH". The logo is simple and eye-catching, with the company name clearly displayed. Ko 337/7 pge 142 ### FEB 2 5 2004 #### Bonutti Research, Inc., - TranSet™ Fracture Fixation System 510(k) Premarket Notification February 24, 2004 #### 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS The following information is submitted in accordance with the requirements of 21 CFR 807.92: Contact Person: Patrick G. Balsmann, MS, RAC Director RA/QA & Clinical Bonutti Research, Inc. P.O. Box 1367, Effingham, Illinois 62401 Phone: (217) 342-3412, ext. 321 Date Prepared: November 25, 2003 Proprietary Name: TranSet™ Fracture Fixation System. Common Name: Trauma Fracture Fixation System. · Classification Name: 21 CFR 888.3040 Smooth or threaded mctallic bone fixation fastener and 21 CFR 878.4930 Suture retention device. Device Deseription :- The TranSet ... Frantyre Fixation System intended use is in the stabilization and linear fixation of bone or tissue fragments in orthopedic fractures and in ligament and tendon repair and reconstruction. The system consists of both absorbable and titanium cylindrical huttons manufactured from poly-L-lactic acid or titanium alloy. The buttons are provided sterile packaged with or without braided suture and are intended for single-patient use. Buttons are applied to the outer bone cortex and with suture ruming across the fracture site allows for stabilization and linear fixation of the bone or tissue fragments. This allows the bone or tissue fragments to be compressed and held together to promote healing. The cylindrical design of the buttons also allows them to be used as fixation devices in orthopedic ligament and tendon repair and reconstruction. The buttons are placed outside the cortical bone or though a soft tissue repair site and act as fixation posts by distributing suture tension over larger areas to promote healing and eliminate any suture tearing or pulling through the tissue. The absorbable buttons degrade over time and eliminate the need for any surgical removal. Removal of the titanium buttons is based upon surgeon preference. Reusable manual surgical instrumentation for insertion of the buttons and a sterilization tray for autoclaving complete the system. {1}------------------------------------------------ K033717 page 1 of 1 Indications for Use: The TranSct"™ Fracture Fixation System is indicated as an adjunct in fracture repair involving metaphyseal and periarticular small bone fragments where screws are not indicated. It may also be used as an adjunct to external and intramedullary fixation systems involving fixation plates and rods, with fracture braces and casting, and with bone graft substitutes. The system is also indicated in ligament and tendon repair and reconstruction associated with fractures and soft tissue reattachment including ligament/tendon avulsions and meniscal repairs. The system consists of both absorbable and titanium fixation buttons used with up to USP Size No. 5-braided suture and are not intended for reuse. The system may also be used with the Unity Ultrasonic Fixation seat for tissue approximation and ligation when using USP Size No. 2-0 through 2-braided suture. Custom manual surgical instrumentation for button insertion and a sterilization tray complete the TranSctTM Fracture Fixation System. The TranSet™ Fracture Fixation System is not indicated for use in intra-articular sites. Predicate Device (s): The TranSet " Fracture Fixation System is similar in intended use and materials to the Multitak SS Buttons (K990156), Linvatec, Corp., BioButton™ (K990194) and Inion, Ltd., OTPS 10 Biodegradable pins (K031712). The TranSet 1 Fracture Fixation System buttons are also similar in design and materials to the Multitak SS Buttons and the Multitak Splinter 3.0 mm Resorbable Anchors (K012456). Predicate Comparison: Performance testing comparing the mechanical strengths and failure modes of the TranSet™ Fracture Fixation System absorbable and titanium buttons to stainless steel Steinmann Pins commonly used in fracture fixation procedures demonstrated the buttons are statistically equivalent. **Submitted by:** [signature] Patrick G. Balsmann, MS, RAC Director, Regulatory/Clinical Affairs & OA {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the top half of the circle. In the center of the seal is an abstract image of an eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 # FEB 2 5 2004 Mr. Patrick G. Balsmann, MS, RAC Director, Regulatory/Clinical Affairs and Quality Assurance Bonutti Research, Inc. P.O. Box 1367 Effingham, Illinois 62401 Re: K033717 Trade/Device Name: TranSet™ Fracture Fixation System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: II Product Code: HTY Dated: November 25, 2003 Received: November 28, 2003 Dear Mr. Balsmann: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that I·DA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ # Page 2 - Mr. Patrick G. Balsmann, MS, RAC This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will anow you to oegin maing of substantial equivalence of your device to a legally prematicated predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice for your ac (301) 594-4639. Also, please note the regulation entitled, contact the Ories of Come to premarket notification" (21CFR Part 807.97) you may obtain. . Misorunation on your responsibilities under the Act may be obtained from the Other general information on your respectional and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Mark A. Millikum Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Indications for Use Koss 717 510(k) Number (if known): TranSet™ Fracture Fixation System. Device Name: Indications For Use: Indications for Use: The TranSet™ Franction System is indicated as an adjunct in there serest Indications for Use: The Transcl fracture repair involving melapliysed as an adjunct to external and intramedullary fixation are not indicated. It may also be last as an allunces and casting, and with bone systems involving fixation plates and roline to ligners and rendon repair and systems involving fixation plates and rous, with ligament and tendon repair and graft substitutes. The system is also manages and soft tissue realtachment including reconstruction avulsions and meniscal repairs. The system consists of both absorbable and ligament/tendon avulsions and member 10 USP Size No. 5-braided sutture and are not intended titanium fixation buttons used with up to USP Size No. 5-bration seat for tissue titanium fixation buttons used with the Unity Uitrasonic Fixation seat for tissue for reuse. The system may also be used with the Unity 2-D through 3-baided sulure. Clust for reuse. The system may also be used with the Unity Onlines of Straided sulure. Custom approximation and ligation when issues and as sterligation trav complete the approximation and ligation when using UST 3120 No. I 6 all 05 manual surgical instrumentation for button insertion and a sterilization tray complete the TranSet IM Fracture Fixation System. The TranSet™ Fracture Fixation System is not indicated for use in intra-articular sites. Prescription Use _ A (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use _ No (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) > Braluation (ODE) H. Office of Device Concurrence of CDF Mark N. Milliken Division of General, Restorative, and Neurological Devices Page 1 of Number_
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%